Ilex Medical Ltd.

  • Market Cap: N/A
  • Industry: Retailing
  • ISIN: IL0010807530
ILS
54.32
0.37 (0.69%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
245.69
227.57
219.31
238.26
231.96
240.10
218.85
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
245.69
227.57
219.31
238.26
231.96
240.10
218.85
Raw Material Cost
190.34
175.57
169.67
183.36
179.44
182.62
168.12
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.51
0.61
0.46
0.83
0.92
1.22
4.46
Selling and Distribution Expenses
38.76
36.26
35.61
37.35
36.59
37.41
37.97
Other Expenses
0.13
0.14
0.15
0.13
0.09
0.16
-0.20
Total Expenditure (Excl Depreciation)
230.93
213.81
207.28
222.88
217.88
222.88
208.52
Operating Profit (PBDIT) excl Other Income
14.8
13.799999999999999
12
15.4
14.1
17.2
10.3
Other Income
12.29
4.31
5.73
1.75
0.35
4.55
3.46
Operating Profit (PBDIT)
39.67
30.92
29.90
29.04
27.56
34.00
25.54
Interest
0.51
0.61
0.46
0.83
0.92
1.22
4.46
Exceptional Items
1.32
0.65
7.07
-1.88
0.86
0.00
0.00
Gross Profit (PBDT)
55.35
52.00
49.64
54.90
52.52
57.48
50.73
Depreciation
12.61
12.85
12.13
11.92
13.13
12.24
11.75
Profit Before Tax
27.86
18.11
24.38
14.41
14.37
20.54
9.32
Tax
4.75
4.91
5.65
3.27
4.36
5.43
2.42
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
18.53
10.99
16.92
9.11
7.67
12.96
5.49
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
18.53
10.99
16.92
9.11
7.67
12.96
5.49
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
18.53
10.99
16.92
9.11
7.67
12.96
5.49
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
684.71
673.74
660.36
646.41
646.49
641.83
628.76
Earnings per share (EPS)
1.66
0.98
1.51
0.81
0.59
1.16
0.49
Diluted Earnings per share
1.66
0.98
1.51
0.81
0.59
1.16
0.49
Operating Profit Margin (Excl OI)
6.01%
6.05%
5.49%
6.45%
6.07%
7.17%
4.72%
Gross Profit Margin
16.47%
13.6%
16.65%
11.05%
11.85%
13.65%
9.63%
PAT Margin
7.54%
4.83%
7.72%
3.82%
3.3%
5.4%
2.51%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 7.95% vs 3.78% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 68.18% vs -34.91% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 3.01% vs 9.92% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -16.67% vs 20.00% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Ilex Medical Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(ILS)
Change(%)
Net Sales
245.69
0
245.69
Other Operating Income
0.00
0.00
0.00
Total Operating income
245.69
0
245.69
Raw Material Cost
190.34
0
190.34
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.51
0
0.51
Selling and Distribution Expenses
38.76
0
38.76
Other Expenses
0.13
0.00
0.13
Total Expenditure (Excl Depreciation)
230.93
0
230.93
Operating Profit (PBDIT) excl Other Income
14.76
0.00
14.76
Other Income
12.29
0
12.29
Operating Profit (PBDIT)
39.67
0
39.67
Interest
0.51
0
0.51
Exceptional Items
1.32
0
1.32
Gross Profit (PBDT)
55.35
0
55.35
Depreciation
12.61
0
12.61
Profit Before Tax
27.86
0
27.86
Tax
4.75
0
4.75
Provisions and contingencies
0
0
0.00
Profit After Tax
18.53
0
18.53
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
18.53
0
18.53
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
18.53
0
18.53
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
684.71
0
684.71
Earnings per share (EPS)
1.66
0
1.66
Diluted Earnings per share
1.66
0
1.66
Operating Profit Margin (Excl OI)
6.01%
0%
0.00
6.01%
Gross Profit Margin
16.47%
0%
0.00
16.47%
PAT Margin
7.54%
0%
0.00
7.54%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 24.57 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 7.95% vs 3.78% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 5.91% vs -18.34% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.85 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 68.18% vs -34.91% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 140.26% vs -65.62% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.74 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 3.01% vs 9.92% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 0.74% vs -23.16% in Dec 2024

Quarterly - Interest
Interest 0.05 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -16.67% vs 20.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -44.44% vs 12.50% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.01%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024